Talk from Dr. Jill James on evidence for epigenetic dysregulation and mitochondrial dysfunction in ASDs.
Published: 02/3/2016
Dr. James is a Research Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences and the Director of the Autism Metabolic Genomics Laboratory at the Arkansas Children’s Hospital Research Institute. She received her undergraduate degree from Mills College in Oakland, CA and her doctorate in Nutritional Biochemistry from UCLA. Dr. James has more than 25 years of research experience and is nationally and internationally recognized as an expert in on folate and glutathione metabolism. Her research has been funded by NIH and the Department of Defense and is focused on metabolic, genetic, and epigenetic abnormalities in children with autism and their mothers.
Biomarkers start telling us a story: Autism pathophysiology revisited
Learn about emerging research on biomarkers and autism from a recent ARI Research Grant recipient. This is a joint presentation with the World Autism Organisation. The presentation by Dr.
The Low-Hanging Fruit: Exploring Monogenic Syndromes with Elevated Rates of Autism
Learn research updates on how genes associated with autism are functioning in the brain and how changes in these genes are linked to characteristics of autism and other conditions.
New research points to alterations in BPA excretion pathway in children with autism, ADHD
Children with autism spectrum disorders (ASD) may have a reduced ability to detoxify the chemical bisphenol A (BPA), according to new research. BPA is an industrial “plasticizer” used in plastic water bottles, food
Animal study adds to evidence of link between pyrethroids and autism
A new animal study adds to evidence that prenatal exposure to common insecticides called pyrethroids may increase the likelihood of a child developing autism or another neurodevelopmental disorder. Melissa Curtis and colleagues,
Prenatal exposure to cannabis may increase likelihood of autism
Cannabis use during pregnancy may alter placental and fetal DNA methylation (the process of turning genes “on” and “off”) in ways that increase the likelihood of autism spectrum disorder (ASD) or other
Gestational Influences and Autism
Dr. Judy Van de Water, Ph.D., explores the role of gestational factors in the development of autism. She explains how maternal immune activation, antibody patterns, and immune markers play significant roles in neurodevelopment